Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose Effect of Tranexamic Acid on DVT in Cardiac Surgery
NCT03838328Phase 4Unknown
- Sponsor
- CSPC Pharmaceutical Group
- Start
- Mar 2019
- Primary completion
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of tranexamic acid in hemorrhage (3 arms), sponsored by CSPC Pharmaceutical Group. Primary endpoint: Deep Venous Thrombosis incidence at 7 days. Status: unknown.
02
Drugs
tranexamic acid
03
Conditions
hemorrhage
Beyond the preview
Go deeper on NCT03838328.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03838328.